Application Note: In-solution measurement of antibody affinities and binding stoichiometries to neurotoxic amyloid species
18 August 2022

Accurate characterization of the interaction between antibodies and aggregate species such as pathogenic oligomeric or fibrillar forms of proteins like α-synuclein (Parkinson’s disease) or A-β peptide (Alzheimer’s disease proves to be challenging for most technologies. Find the solution in this application note by Fluidic Analytics.